Psoriatic arthritis: complexities, comorbidities and implications for the clinic

被引:32
作者
Haroon, Muhammad [1 ,2 ]
FitzGerald, Oliver [3 ,4 ]
机构
[1] Univ Hosp Kerry, Dept Med, Div Rheumatol, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Dublin, Dublin 4, Ireland
[3] St Vincents Univ Hosp, Dept Rheumatol, Elm Pk, Dublin 4, Ireland
[4] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol Res, Dublin 4, Ireland
关键词
psoriatic arthritis; treatment; comorbidities; INCREASED ARTERIAL STIFFNESS; QUALITY-OF-LIFE; METABOLIC SYNDROME; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; DEPRESSIVE SYMPTOMS; SPANISH PATIENTS; SCREENING TOOLS;
D O I
10.1586/1744666X.2016.1139453
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory disease that affects peripheral joints, entheses and axial sites in addition to both skin and nails. There is considerable evidence to support the assertion that PsA is actually a multisystem disease. Contrary to earlier beliefs, PsA is not only common but also a potentially deforming and disabling disease. In addition to the characteristic extra-articular features, such as uveitis and inflammatory bowel disease, patients with PsA may also suffer from co-existing diseases, referred to as comorbidities. The presence of both extra-articular manifestations and comorbidities may have consequences for the treatment, prognosis and outcome of the disease, which frequently go unrecognized or undertreated. The following review article describes the complexities and comorbidities of PsA as well as their implications for the clinic.
引用
收藏
页码:405 / 416
页数:12
相关论文
共 93 条
[1]   Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis [J].
Ademowo, Opeyemi S. ;
Hernandez, Belinda ;
Collins, Emily ;
Rooney, Cathy ;
Fearon, Ursula ;
van Kuijk, Arno W. ;
Tak, Paul-P ;
Gerlag, Danielle M. ;
FitzGerald, Oliver ;
Pennington, Stephen R. .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) :234-241
[2]  
Alamanos Y, 2008, J RHEUMATOL, V35, P1354
[3]  
[Anonymous], 2000, World Health Organization Technical Report Series, V894, P1253
[4]  
[Anonymous], 2012, DHHS PUBLICATION
[5]   Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study [J].
Belinchon, I. ;
Vanaclocha, F. ;
de la Cueva-Dobao, P. ;
Coto-Segura, P. ;
Labandeira, J. ;
Herranz, P. ;
Taberner, R. ;
Julia, B. ;
Cea-Calvo, L. ;
Puig, L. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (04) :318-325
[6]   A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis [J].
Bostoen, J. ;
Van Praet, L. ;
Brochez, L. ;
Mielants, H. ;
Lambert, J. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (04) :507-511
[7]   Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project [J].
Castaneda, Santos ;
Martin-Martinez, Maria A. ;
Gonzalez-Juanatey, Carlos ;
Llorca, Javier ;
Garcia-Yebenes, Maria J. ;
Perez-Vicente, Sabina ;
Sanchez-Costa, Jesus T. ;
Diaz-Gonzalez, Federico ;
Gonzalez-Gay, Miguel A. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) :618-626
[8]  
CATSAROUCATSARI A, 1984, ACTA DERM-VENEREOL, V64, P557, DOI 10.2340/0001555564557559
[9]   Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study) [J].
Coates, L. C. ;
Aslam, T. ;
Al Balushi, F. ;
Burden, A. D. ;
Burden-The, E. ;
Caperon, A. R. ;
Cerio, R. ;
Chattopadhyay, C. ;
Chinoy, H. ;
Goodfield, M. J. D. ;
Kay, L. ;
Kelly, S. ;
Kirkham, B. W. ;
Lovell, C. R. ;
Marzo-Ortega, H. ;
McHugh, N. ;
Murphy, R. ;
Reynolds, N. J. ;
Smith, C. H. ;
Stewart, E. J. C. ;
Warren, R. B. ;
Waxman, R. ;
Wilson, H. E. ;
Helliwell, P. S. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (04) :802-807
[10]   Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial [J].
Coates, Laura C. ;
Moverley, Anna R. ;
McParland, Lucy ;
Brown, Sarah ;
Navarro-Coy, Nuria ;
O'Dwyer, John L. ;
Meads, David M. ;
Emery, Paul ;
Conaghan, Philip G. ;
Helliwell, Philip S. .
LANCET, 2015, 386 (10012) :2489-2498